Honeybee venom
Trade name: apitox
Animal productexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
2
Phase 4
0
Earliest trial started Dec 1, 2013 (NCT01112722)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 3 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- apitox
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07135609 | N/A | Apr 30, 2024 | Tanta University |
| NCT03710655 | Phase 3 | Apr 30, 2019 | Apimeds |
| NCT01112722 | Phase 3 | Dec 1, 2013 | Apimeds |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Apimeds | For profit | 2 | 2 | 1 | 2013 |
| Tanta University | Academic/Hospital | 1 | 1 | 1 | 2024 |
2 organizations
Page 1 / 1